CPP Investment Board

Waystar Survey Finds Health System Leaders Optimistic About Future of AI

Retrieved on: 
Tuesday, October 12, 2021

According to the survey, RPA and AI usage remains inconsistent across the various parts of the revenue cycle.

Key Points: 
  • According to the survey, RPA and AI usage remains inconsistent across the various parts of the revenue cycle.
  • What's more, health system leaders are overwhelmingly interested in automation and optimistic about the role AI can play for their organization.
  • Additional findings from the survey include:
    RPA and AI help improve efficiency: One of the most compelling benefits of RPA and AI is their ability to streamline key processes throughout the revenue cycle.
  • The Waystar platform supports more than 500,000 providers, 1,000 health systems and hospitals, and 5,000 payers and health plans.

Caris Life Sciences Announces Appointment of Mike Weinstein, Medical Technology Executive and Wall Street Veteran, as Chief Financial Officer

Retrieved on: 
Wednesday, October 6, 2021

IRVING, Texas, Oct. 6, 2021 /PRNewswire/ -- Caris Life Sciences ,a molecular science company developing and delivering technologies to revolutionize healthcare, announced today the appointment of Mike Weinstein as Executive Vice President and Chief Financial Officer.

Key Points: 
  • IRVING, Texas, Oct. 6, 2021 /PRNewswire/ -- Caris Life Sciences ,a molecular science company developing and delivering technologies to revolutionize healthcare, announced today the appointment of Mike Weinstein as Executive Vice President and Chief Financial Officer.
  • "We are thrilled to welcome Mike to the Caris team," said David D. Halbert , Chairman and CEO of Caris Life Sciences.
  • In May, Caris announced an $830 million growth equity round at a $7.83 billion post-money valuation.
  • The round was led by Sixth Street, a leading global investment firm making its third investment in Caris since 2018.

Ascot Group Implements Guidewire Cyence for Cyber Insurance Growth

Retrieved on: 
Tuesday, October 5, 2021

Ascot Group and Guidewire Software, Inc. (NYSE: GWRE) today announced that Ascots United States insurance company, Ascot U.S., is using Guidewire Cyence risk selection and accumulation management products to leverage market-leading, internet-scale cyber data listening and modeling capabilities to grow their cyber line of business.

Key Points: 
  • Ascot Group and Guidewire Software, Inc. (NYSE: GWRE) today announced that Ascots United States insurance company, Ascot U.S., is using Guidewire Cyence risk selection and accumulation management products to leverage market-leading, internet-scale cyber data listening and modeling capabilities to grow their cyber line of business.
  • Matthew Kramer, chief executive officer, Ascot U.S., said, Ascot is delighted to partner with Guidewire to assist our underwriting teams with continued exceptional service for our clients.
  • The thousands of cyber data points and insights offered by Cyence help our underwriters erode the uncertainty when selecting risks, said Drew Walter, U.S. executive vice president and head of cyber and professional liability, Ascot.
  • Ascot Group is a global specialty insurance and reinsurance group with a record of underwriting excellence and superior claims service.

CPP Investments and Conservation International to invest in nature-based climate solutions

Retrieved on: 
Tuesday, October 5, 2021

TORONTO and ARLINGTON, VA, Oct. 5, 2021 /PRNewswire/ - Canada Pension Plan Investment Board ( CPP Investments ) and Conservation International today announced a new partnership to invest in nature-based climate solutions.

Key Points: 
  • TORONTO and ARLINGTON, VA, Oct. 5, 2021 /PRNewswire/ - Canada Pension Plan Investment Board ( CPP Investments ) and Conservation International today announced a new partnership to invest in nature-based climate solutions.
  • CPP Investments will initially commit US$20 million and Conservation International will commit US$500,000 to this first-of-kind partnership between a global asset owner and a well-established environmental NGO for investments in nature-based solutions within the voluntary carbon market.
  • In addition to these REDD+ projects, the partnership will also invest in other innovations in the field of nature-based climate solutions.
  • Over time, CPP Investments and Conservation International plan to scale the partnership and bring on additional investors to lead large-scale, global development of nature-based climate solutions.

Perfect Day Raises $350 Million to Expand Consumer and Enterprise Biology Platforms

Retrieved on: 
Thursday, September 30, 2021

In mid-2020, Perfect Day added SBF, Inc., a bioprocess scale-up facility located in Logan, Utah, to the corporate portfolio.

Key Points: 
  • In mid-2020, Perfect Day added SBF, Inc., a bioprocess scale-up facility located in Logan, Utah, to the corporate portfolio.
  • Now, in addition to ingredient innovation and consumer products, the company intends to expand its offerings into "enterprise biology," providing technology development services for companies looking to harness the sustainability and scale that Perfect Day has proven it can deliver.
  • SBF, Perfect Day's "enterprise biology" business, is already profitable with a strong roster of customers.
  • Building upon this success, Perfect Day is further investing in TUC with the launch of its next brand, Modern Kitchen.

Private Equity Industry Establishes First-Ever LP and GP Partnership to Standardize ESG Reporting

Retrieved on: 
Thursday, September 30, 2021

The groups objective is to streamline the private equity industrys historically fragmented approach to collecting and reporting ESG data in order to create a critical mass of material, performance-based, comparable ESG data from portfolio companies.

Key Points: 
  • The groups objective is to streamline the private equity industrys historically fragmented approach to collecting and reporting ESG data in order to create a critical mass of material, performance-based, comparable ESG data from portfolio companies.
  • This collaboration is intended to be a long-term mechanism to increase the quality, availability, and comparability of ESG data in private markets.
  • PGGM, as a member of the ESG Metrics Steering Group, will play a role in driving the private equity market towards making more and better ESG disclosures.
  • The effort encourages private equity industry stakeholders to work together to gather better, decision-useful ESG data in order to generate deeper insight into ESG factors and their relationship to financial outcomes, and, ultimately, to drive greater progress on critical ESG issues.

Sinch acquires Pathwire, the leading email delivery platform, and intends to carry out a directed share issue secured by investor undertakings

Retrieved on: 
Thursday, September 30, 2021

Sinch will pay the sellers a cash consideration of USD 925 million and 51 million new shares in Sinch.

Key Points: 
  • Sinch will pay the sellers a cash consideration of USD 925 million and 51 million new shares in Sinch.
  • Pathwires offering is centered around three core products:
    Mailgun offers powerful APIs that let developers integrate automated email messages into products and workflows.
  • Mailjet offers a drag-and-drop email builder and suite of APIs that empower marketers to increase customer engagement and maximize marketing ROI.
  • Sinch further intends to resolve on a directed share issue of approximately 40 million shares, equivalent to approximately USD 750 million.

Great Gulf Announces the Appointment of Two New Board Members

Retrieved on: 
Thursday, September 23, 2021

TORONTO, Sept. 23, 2021 /PRNewswire/ -Jerry Patava, Chair of the Board of Directors (the "Board") of the Great Gulf Group (the "Company") announced today the appointment of Bill Tresham and Stephen Cole to serve on the Company's Board.

Key Points: 
  • TORONTO, Sept. 23, 2021 /PRNewswire/ -Jerry Patava, Chair of the Board of Directors (the "Board") of the Great Gulf Group (the "Company") announced today the appointment of Bill Tresham and Stephen Cole to serve on the Company's Board.
  • "We are excited to welcome Bill and Stephen to our Board.
  • "We look forward to the expertise and knowledge they bring to Great Gulf to further enhance the strategic direction and growth of our organization."
  • With major projects in Canada and the United States, the company's fully-integrated activities span the entire real estate spectrum.

Great Gulf Announces the Appointment of Two New Board Members

Retrieved on: 
Thursday, September 23, 2021

TORONTO, Sept. 23, 2021 /PRNewswire/ -Jerry Patava, Chair of the Board of Directors (the "Board") of the Great Gulf Group (the "Company") announced today the appointment of Bill Tresham and Stephen Cole to serve on the Company's Board.

Key Points: 
  • TORONTO, Sept. 23, 2021 /PRNewswire/ -Jerry Patava, Chair of the Board of Directors (the "Board") of the Great Gulf Group (the "Company") announced today the appointment of Bill Tresham and Stephen Cole to serve on the Company's Board.
  • "We are excited to welcome Bill and Stephen to our Board.
  • "We look forward to the expertise and knowledge they bring to Great Gulf to further enhance the strategic direction and growth of our organization."
  • With major projects in Canada and the United States, the company's fully-integrated activities span the entire real estate spectrum.

Selecta Biosciences Announces Appointment of Kevin Tan as Chief Financial Officer

Retrieved on: 
Monday, September 20, 2021

WATERTOWN, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced the appointment of Kevin Tan as chief financial officer.

Key Points: 
  • WATERTOWN, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced the appointment of Kevin Tan as chief financial officer.
  • Kevins deep financial expertise and experience in the gene therapy and rare disease landscape makes him an ideal fit for Selectas executive team, said Carsten Brunn, Ph.D., president and chief executive officer of Selecta.
  • Mr. Tan added, I am excited to join Selecta at this critical juncture in the companys growth.
  • Prior to joining Selecta, Mr. Tan served as treasurer at Sarepta Therapeutics where he was responsible for the liquidity and capital management of the company.